Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2025 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| NEO-TETRAPRO | CAN-VET ANIMAL HEALTH SUPPLIES LTD. | Marketed | Sep 27, 2022 | Marketed |
| ACH-APIXABAN | Accord Healthcare Inc | Marketed | Sep 27, 2022 | Marketed |
| ACH-APIXABAN | Accord Healthcare Inc | Marketed | Sep 27, 2022 | Marketed |
| PRO-APIXABAN | PRO DOC LIMITEE | Marketed | Sep 26, 2022 | Marketed |
| LEQVIO | novartis pharmaceuticals canada inc | Marketed | Sep 26, 2022 | Marketed |
| PRO-APIXABAN | PRO DOC LIMITEE | Marketed | Sep 26, 2022 | Marketed |
| CAVIWIPES HP | METREX RESEARCH, LLC | Marketed | Sep 23, 2022 | Marketed |
| PMSC-VENLAFAXINE XR | Pharmascience Inc | Marketed | Sep 23, 2022 | Marketed |
| SANDOZ APIXABAN SDZ | Sandoz Canada, Inc. | Marketed | Sep 22, 2022 | Marketed |
| SANDOZ APIXABAN SDZ | Sandoz Canada, Inc. | Marketed | Sep 22, 2022 | Marketed |
| MAR-APIXABAN | marcan pharmaceuticals inc | Marketed | Sep 21, 2022 | Marketed |
| TARO-APIXABAN | sun pharma canada inc | Marketed | Sep 21, 2022 | Marketed |
| NAT-APIXABAN | natco pharma (canada) inc | Marketed | Sep 21, 2022 | Marketed |
| MAR-APIXABAN | marcan pharmaceuticals inc | Marketed | Sep 21, 2022 | Marketed |
| NAT-APIXABAN | natco pharma (canada) inc | Marketed | Sep 21, 2022 | Marketed |
| BIO-APIXABAN | biomed pharma | Marketed | Sep 21, 2022 | Marketed |
| PRZ-AMLODIPINE | pharmaris canada inc | Marketed | Sep 21, 2022 | Marketed |
| TARO-APIXABAN | sun pharma canada inc | Marketed | Sep 21, 2022 | Marketed |
| PRZ-AMLODIPINE | pharmaris canada inc | Marketed | Sep 21, 2022 | Marketed |
| M-APIXABAN | mantra pharma inc | Marketed | Sep 21, 2022 | Marketed |
